Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 May;20(3):421-5.
doi: 10.1111/hae.12319. Epub 2013 Dec 16.

The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia

J U M Calegaro  1 , J Machado, R G Furtado, J S C de Almeida, A V P de Vasconcelos, M F de Barboza, A P de Paula
Affiliations
Free PMC article
Clinical Trial

The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia

J U M Calegaro et al. Haemophilia. 2014 May.
Free PMC article

Abstract

The penetration of beta energy of 153-samarium ((153) Sm) (0.8 MeV) is not only appropriate for synovectomy of median articulations but is possible to improve the radiobiological effect using increased activities. The aim of this study was to assess the effectiveness of 185 MBq and 740 MBq of 153-samarium hydroxyapatite ((153) Sm-HA) in knees of haemophilic patients. Thirty-one patients--36 knees, 30 males, were divided into two groups without coinjection of corticosteroid: A - 14 patients (17 knees) treated with intra-articular dose of 185 MBq of (153) Sm-HA, average age 23 years; B--17 patients (19 knees) with 740 MBq of (153) Sm-HA, average age 21.3 years. The evaluation before and after 1 year of synovectomy used the following criteria: reduction in the number of haemarthroses and use of the coagulation factor and improvement in articular motility. Adverse-effects occurrence was considered too. Early and late scintigraphic studies were performed after synoviorthesis and no joint immobilization was recommended. The reduction in haemarthrosis and use of coagulation factor were: group 1--31.3% and 25%; group 2--81.5% and 79% with P < 0.001 respectively; no significant improvement in knees motility was noted for both groups. Four cases of mild reactional synovitis were observed in each group. The scintigraphic control showed homogenous distribution of the radiopharmaceuticals with no articular escape; the material was considered safe by its permanence in the articulation. We have significant improvement in the synovectomy of haemophilic knees with 740 MBq of (153) Sm-HA; the less penetration of its beta radiation was compensated by the increased biological effect with the higher used activity.

Keywords: comparison between different activities; haemophilia; knees arthropathy; samarium-153.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Examples of immediate and late scintigraphic controls utilized.
See this image and copyright information in PMC

References

    1. Luck JV, Jr, Kasper CKL. General orthopedics: a tribute to J. Vernon Luck. Symposium: Surgical management of advanced hemophilic arthropathy: an overview of 20 years’ experience. Clin Orthop. 1989;242:60. - PubMed
    1. Rodriguez-Merchan EC, Jimenez-Yuste V, Aznar JA, et al. Joint protection in haemophilia. Haemophilia. 2011;17(Suppl. 2):1–23. - PubMed
    1. Jansen NW, Roosendaal G, Bijlisma JW, et al. Degenerated and healthy cartilage are equally vulnerable to blood-induced damage. Ann Rheum Dis. 2008;67:1468–73. - PubMed
    1. Ahlberg A. Radioactive gold in the treatment of chronic synovial effusion on hemophilia. In: Ana F, Denson KWE, editors. Proc VII Congress World Federation of Hemophilia. Amsterdam, Holland: Teherat Excerpta Medica; 1971. pp. 212–5.
    1. Ahlberg A, Pettersson H. Synoviorthesis with radioactive gold in hemophiliacs. Clinical and radiological follow-up. Acta Orthop Scand. 1979;50:513–27. - PubMed

MeSH terms